# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2422981 | A | Drug metabolism assessed as enhanced intracellular survival protein (unknown origin)-mediated conversion at 100 uM by micro plate reader analysis relative to tobramycin | Not specified | 4 | cell-based format | Scientific Literature | ||
2. | ALA2422982 | A | Drug metabolism assessed as aminoglycoside 2'-N-acetyltransferase Ic (unknown origin)-mediated conversion at 100 uM by micro plate reader analysis relative to tobramycin | Not specified | 4 | assay format | Scientific Literature | ||
3. | ALA2422983 | A | Drug metabolism assessed as aminoglycoside 6'-N-acetyltransferase Ib' (unknown origin)-mediated conversion at 100 uM by micro plate reader analysis relative to tobramycin | Not specified | 4 | assay format | Scientific Literature | ||
4. | ALA2422984 | A | Drug metabolism assessed as aminoglycoside 3-N-acetyltransferase AAC(3)-IV (unknown origin)-mediated conversion at 100 uM by micro plate reader analysis relative to tobramycin | Not specified | 4 | assay format | Scientific Literature | ||
5. | ALA2422985 | A | Drug metabolism assessed as bifunctional AAC/APH (AAC(6') (unknown origin)-mediated conversion at 100 uM by micro plate reader analysis relative to tobramycin | Not specified | 3 | assay format | Scientific Literature | ||
6. | ALA2422986 | F | Inhibition of protein synthesis in Escherichia coli S30 extracts after 90 mins by coupled transcription/translation assay | Escherichia coli | 15 | organism-based format | Scientific Literature | ||
7. | ALA2422987 | F | Antibacterial activity against biofilm negative Staphylococcus epidermidis ATCC 12228 by double-dilution technique | Staphylococcus epidermidis | 15 | organism-based format | Scientific Literature | ||
8. | ALA2422988 | F | Antibacterial activity against Bacillus anthracis 34F2 Sterne by double-dilution technique | Bacillus anthracis | 15 | organism-based format | Scientific Literature | ||
9. | ALA2422989 | F | Antibacterial activity against Haemophilus influenzae ATCC 51907 by double-dilution technique | Haemophilus influenzae | 15 | organism-based format | Scientific Literature | ||
10. | ALA2422990 | F | Antibacterial activity against Escherichia coli MC1061 by double-dilution technique | Escherichia coli | 15 | organism-based format | Scientific Literature | ||
11. | ALA2422991 | F | Antibacterial activity against Staphylococcus aureus ATCC 29213 by double-dilution technique | Staphylococcus aureus | 15 | organism-based format | Scientific Literature | ||
12. | ALA2422992 | F | Antibacterial activity against Staphylococcus aureus expressing NorA by double-dilution technique | Staphylococcus aureus | 15 | organism-based format | Scientific Literature | ||
13. | ALA2422993 | F | Antibacterial activity against Mycobacterium smegmatis str. MC2 155 by double-dilution technique | Mycolicibacterium smegmatis | 15 | organism-based format | Scientific Literature | ||
14. | ALA2421301 | F | Antibacterial activity against Bacillus cereus ATCC 11778 by double-dilution technique | Bacillus cereus | 15 | organism-based format | Scientific Literature | ||
15. | ALA2421302 | F | Antibacterial activity against Listeria monocytogenes ATCC 19115 by double-dilution technique | Listeria monocytogenes | 15 | organism-based format | Scientific Literature | ||
16. | ALA2421303 | F | Antibacterial activity against Bacillus subtilis 168 harboring AAC(6')/APH(2'')-pRB374 by double-dilution technique | Bacillus subtilis | 15 | organism-based format | Scientific Literature | ||
17. | ALA2421304 | F | Antibacterial activity against Bacillus subtilis 168 by double-dilution technique | Bacillus subtilis | 15 | organism-based format | Scientific Literature | ||
18. | ALA2421305 | F | Antibacterial activity against Streptococcus pyogenes Serotype M12 MGAS9429 by double-dilution technique | Streptococcus pyogenes | 15 | assay format | Scientific Literature |